Shikiar Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,965
Closed -$459K 85
2020
Q2
$459K Buy
5,965
+1,715
+40% +$131K 0.21% 56
2020
Q1
$318K Buy
+4,250
New +$294K 0.21% 63
2017
Q2
Sell
-12,050
Closed -$818K 117
2017
Q1
$818K Sell
12,050
-12,150
-50% -$854K 0.37% 51
2016
Q4
$1.73M Sell
24,200
-41,440
-63% -$3.08M 0.76% 34
2016
Q3
$5.19M Sell
65,640
-26,745
-29% -$2.17M 2.3% 16
2016
Q2
$7.71M Buy
92,385
+20,650
+29% +$1.83M 3.44% 9
2016
Q1
$6.59M Sell
71,735
-31,925
-31% -$2.88M 3.04% 12
2015
Q4
$10.5M Sell
103,660
-5,165
-5% -$537K 5.08% 3
2015
Q3
$10.7M Buy
108,825
+4,015
+4% +$446K 5.52% 2
2015
Q2
$12.3M Buy
104,810
+27,455
+35% +$3M 5.6% 2
2015
Q1
$7.59M Buy
+77,355
New +$7.85M 3.3% 9

Other funds holding GILD

Shikiar Asset Management's GILD Position: Q3 2020 in Review

Shikiar Asset Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 5,965 shares — an estimated $459K sold.

Shikiar Asset Management first reported a position in GILD in Q1 2015 and held it in 11 quarters. The position peaked at $12.3M in Q2 2015. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Shikiar Asset Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Shikiar Asset Management sold 5,965 Gilead Sciences shares in Q3 2020, an estimated $459K.
  • Shikiar Asset Management first reported a position in Gilead Sciences in Q1 2015 and held it in 11 quarters.
  • Shikiar Asset Management's Gilead Sciences position peaked at $12.3M in Q2 2015.
  • 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Shikiar Asset Management's 13F filing for Q3 2020, filed 28 Oct 2020.